TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,661,000 | +403.3% | 22,082 | +79.4% | 0.01% | +550.0% |
| Q1 2022 | $330,000 | -41.4% | 12,307 | +4.3% | 0.00% | -33.3% |
| Q4 2021 | $563,000 | -21.5% | 11,803 | +9.4% | 0.00% | -25.0% |
| Q3 2021 | $717,000 | -1.0% | 10,788 | +16.2% | 0.00% | 0.0% |
| Q2 2021 | $724,000 | -5.1% | 9,283 | +15.1% | 0.00% | -20.0% |
| Q1 2021 | $763,000 | +48.4% | 8,066 | +91.1% | 0.01% | +66.7% |
| Q4 2020 | $514,000 | – | 4,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |